Rational multitargeted drug design strategy from the perspective of a medicinal chemist

X Li, X Li, F Liu, S Li, D Shi - Journal of Medicinal Chemistry, 2021 - ACS Publications
The development of multitarget-directed ligands (MTDLs) has become a widely focused
research topic, but rational design remains as an enormous challenge. This paper reviews …

5-Ene-4-thiazolidinones–An efficient tool in medicinal chemistry

D Kaminskyy, A Kryshchyshyn, R Lesyk - European journal of medicinal …, 2017 - Elsevier
The presented review is an attempt to summarize a huge volume of data on 5-ene-4-
thiazolidinones being a widely studied class of small molecules used in modern organic and …

Medicinal chemistry of tetrazoles

VA Ostrovskii, RE Trifonov, EA Popova - Russian Chemical Bulletin, 2012 - Springer
Abstract Properties of responsible for biological activity tetrazoles are considered. Examples
are given of active pharmaceutical ingredients of modern drugs containing the tetrazole ring …

A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities

SM Mousavi, M Zarei, SA Hashemi… - Artificial cells …, 2019 - Taylor & Francis
Rhodanines are accepted as advantaged heterocycles in medicinal chemistry as one of the
4-thiazolidinones subtypes. The aim of this paper is to analyze the features of rhodanine and …

Rhodanine as a privileged scaffold in drug discovery

T Tomasic, LP Masic - Current Medicinal Chemistry, 2009 - ingentaconnect.com
Rhodanines, thiazolidine-2, 4-diones and pseudothiohydantoins have become a very
interesting class of heterocyclic compounds since the introduction of various glitazones and …

Recent developments with rhodanine as a scaffold for drug discovery

D Kaminskyy, A Kryshchyshyn… - Expert Opinion on Drug …, 2017 - Taylor & Francis
Introduction: Rhodanines, as one of the 4-thiazolidinones subtypes, are recognized as
privileged heterocycles in medicinal chemistry. The main achievements include the …

Advances in docking

VB Sulimov, DC Kutov… - Current medicinal …, 2019 - ingentaconnect.com
Background: Design of small molecules which are able to bind to the protein responsible for
a disease is the key step of the entire process of the new medicine discovery. Atomistic …

Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors

ML Barreca, S Ferro, A Rao, L De Luca… - Journal of medicinal …, 2005 - ACS Publications
Using a training set of diketo-like acid HIV-1 integrase (IN) strand-transfer inhibitors, a 3D
pharmacophore model was derived having quantitative predictive ability in terms of activity …

Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives

H Ju, J Zhang, B Huang, D Kang, B Huang… - Journal of Medicinal …, 2017 - ACS Publications
Influenza virus (IFV) causes periodic global influenza pandemics, resulting in substantial
socioeconomic loss and burden on medical facilities. Yearly variation in the effectiveness of …

Success stories of computer‐aided design

H Kubinyi - Computer applications in pharmaceutical research …, 2006 - Wiley Online Library
Success stories of computer‐aided design Page 395 377 16 SUCCESS STORIES OF
COMPUTER-AIDED DESIGN Hugo Kubinyi Contents 16.1 Introduction 16.2 Receptors 16.2. 1 G …